Recent Regulatory Developments

January 27, 2023
EPA Proposes SNUR for PFAS Designated as Inactive on the TSCA Inventory
January 26, 2023
HSE Begins Public Consultation on Changes to GB BPR Data Requirements
January 25, 2023
EPA Requests Comment on NAMs to Screen for Endocrine Effects
January 23, 2023
EPA Announces Next Test Order Issued under National Testing Strategy for PFAS Used in Plastics, Chemical Manufacturing
January 19, 2023
EPA Finds TCE, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health
January 18, 2023
Congress Enacts Modernization of Cosmetics Regulation Act of 2022, Significantly Strengthening Regulation of Cosmetics
January 9, 2023
Canada Amends Hazardous Products Regulations to Align with GHS Revs 7 and 8
January 6, 2023
Forecast for U.S. Federal and International Chemical Regulatory Policy 2023
December 28, 2022
EPA Finds Carbon Tetrachloride, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health
December 21, 2022
EPA Finds PCE, NMP, and 1-BP, as Whole Chemical Substances, Pose Unreasonable Risks to Human Health
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
THE ACTA GROUP
Beijing, China | Brussels, Belgium | Manchester, U.K. | Washington, D.C.
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy
©2023 The Acta Group All Rights Reserved.